► Customized research for MLNT vs. BIOQ!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for MLNT vs. BIOQ.
↗ Join Our Free Email Newsletter.
► Melinta Therapeutics Inc. vs. BIOQUAL, Inc.
Industry Match! Industry of Both MLNT and BIOQ:
Health Care/Life Sciences
MLNT
Data Last Updated: More than 3 wks ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 27.614M
P/E: N/A
P/S: 0.29
Q P/B: 0.19
Y Rev: 96.43M
Q Rev: 15.96M
Beta: 7.14

MLNT Share Stats
► Outstanding Shares
11.78M
► Float Shares
10.37M
► Percent of Float Short
19.93%
MLNT Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
MLNT Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share MLNT Insights
MLNT Profile
► CEO
Ms. Jennifer A. Sanfilippo
► Exchange
Nasdaq
► Employees
290.00
► About
Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv,...

MLNT Financials
Annual Financials
Income Statement
► Revenue
96.43M
► Net Income
(157.19M)
Cash Flow Statement
► Change in Cash / Investments
(46.58M)
Balance Sheet
► Cash / Investments
81.81M
► Short Term Debt
None
► Long Term Debt
110.48M
► Total Current Assets
149.48M
► Total Current Liabilities
133.61M
► Total Assets
441.59M
► Total Liabilities
251.53M
► Stockholder Equity
190.06M
Quarterly Financials
Income Statement
► Q Revenue
15.96M
► Q Net Income
(36.18M)
Cash Flow Statement
► Q Change in Cash / Investments
(26.56M)
Balance Sheet
► Q Cash / Investments
90.34M
► Q Short Term Debt
13.79M
► Q Long Term Debt
157.06M
► Q Total Current Assets
156.76M
► Q Total Current Liabilities
132.39M
► Q Total Assets
440.37M
► Q Total Liabilities
298.71M
► Q Stockholder Equity
141.67M

MLNT Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

BIOQ
Data Last Updated: 5 hours ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 5.2M
P/E: 12.53
P/S: 0.13
Q P/B: 0.2
Y Rev: 39.48M
Q Rev: 10.07M
Beta: 0.18

BIOQ Share Stats
► Outstanding Shares
0.90M
► Float Shares
0.89M
► Percent of Float Short
N/A
BIOQ Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
0%
BIOQ Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share BIOQ Insights
BIOQ Profile
► CEO
Dr. Mark G. Lewis
► Exchange
OTC
► Employees
N/A
► About
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. It focuses on animal models of human diseases including AIDS, influenza, RSV infection, flavivirus infections, malaria,...

BIOQ Financials
Annual Financials
Income Statement
► Revenue
39.48M
► Net Income
2.83M
Cash Flow Statement
► Change in Cash / Investments
(953,002)
Balance Sheet
► Cash / Investments
9.21M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
21.27M
► Total Current Liabilities
2.78M
► Total Assets
28.31M
► Total Liabilities
3.75M
► Stockholder Equity
24.56M
Quarterly Financials
Income Statement
► Q Revenue
10.07M
► Q Net Income
1.32M
Cash Flow Statement
► Q Change in Cash / Investments
(867,225)
Balance Sheet
► Q Cash / Investments
8.34M
► Q Short Term Debt
2.79M
► Q Long Term Debt
None
► Q Total Current Assets
22.14M
► Q Total Current Liabilities
5.08M
► Q Total Assets
45.66M
► Q Total Liabilities
19.77M
► Q Stockholder Equity
25.89M

BIOQ Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

